are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, even after undergoing systemic therapy, patients may have oligometastatic disease. "A lot of patients respond ...

Oligometastatic Disease Market Forecast DelveInsight's Oligometastatic Disease Market report offers an in-depth understanding of the epidem ...

Medscape Medical News, August 23, 2024 Few Severe Toxicities After SBRT in Oligometastatic Cancer Just 0.5% of patients receiving SBRT to treat oligometastatic cancer experienced severe adverse ...

Reuters Health Information, August 19, 2024 Few Severe Toxicities After SBRT in Oligometastatic Cancer Just 0.5% of patients receiving SBRT to treat oligometastatic cancer experienced severe ...

Metastatic cancer is when cancer begins in one part ... She said this is classed as oligometastatic "which means it has spread to just one or two small places you might be able to deal with ...